Uveal melanoma treated with iodine-125 episcleral plaque: an analysis of dose on disease control and visual outcomes.
about
Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy.Iodine-125 Brachytherapy for Uveal Melanoma: A Systematic Review of Radiation Dose.Percutaneous implantation of (125)iodine seeds for treatment of portal vein tumor thrombosis in hepatocellular carcinoma.Visual outcome after posterior uveal melanoma episcleral brachytherapy including radiobiological doses.Radiobiological doses, tumor, and treatment features influence on local control, enucleation rates, and survival after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: part I
P2860
Uveal melanoma treated with iodine-125 episcleral plaque: an analysis of dose on disease control and visual outcomes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Uveal melanoma treated with io ...... e control and visual outcomes.
@en
Uveal melanoma treated with io ...... e control and visual outcomes.
@nl
type
label
Uveal melanoma treated with io ...... e control and visual outcomes.
@en
Uveal melanoma treated with io ...... e control and visual outcomes.
@nl
prefLabel
Uveal melanoma treated with io ...... e control and visual outcomes.
@en
Uveal melanoma treated with io ...... e control and visual outcomes.
@nl
P2093
P2860
P1476
Uveal melanoma treated with io ...... e control and visual outcomes.
@en
P2093
Ali Alkaissi
Beverly A Steffey
Bradford A Perez
David G Kirsch
Douglas Rivera
Edward G Buckley
Edward Halperin
Jonathan J Dutton
Lawrence B Marks
Lejla Vajzovic
P2860
P304
P356
10.1016/J.IJROBP.2014.01.026
P407
P50
P577
2014-03-07T00:00:00Z